(Total Views: 449)
Posted On: 10/05/2020 12:00:50 PM
Post# of 35
$ARCT News Article - Arcturus Therapeutics Announces Completion of First Three Dose Escalation Cohorts in Phase 1 Study of ARCT-810, Therapeutic Candidate for Ornithine Transcarbamylase (OTC) Deficiency https://marketwirenews.com/news-releases/arct...83139.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
